Assessment of morphometric measurements of prostate carcinoma volume

Cancer

Volumn 89, Issue 5, 2000, Pages 1056-1064

  Noguchi, Masanori ^a   Stamey, Thomas A ^a   McNeal, John E ^a   Yemoto, Cheryl E M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Computer assisted image analysis; Prostate carcinoma; Radical prostatectomy; Tumor volume

Indexed keywords

ACCURACY; ARTICLE; CANCER GRADING; CANCER GROWTH; CELL STRUCTURE; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RELIABILITY; TUMOR VOLUME;

DATA INTERPRETATION, STATISTICAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; NATIONAL INSTITUTES OF HEALTH (U.S.); PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY CONTROL; SOFTWARE; UNITED STATES;

EID: 0034284336     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000901)89:5<1056::AID-CNCR15>3.0.CO;2-U     Document Type: Article

References (23)

1. Patterns of progression in prostate cancer
2. Capsular penetration in prostate cancer: Significance for natural history and treatment
3. Histologic differentiation, cancer volume and pelvic lymph node metastasis in adenocarcinoma of the prostate
4. Biological determinants of cancer progression in men with prostate cancer
5. Localized prostate cancer: Relationship of tumor volume to clinical significance for treatment of prostate cancer
6. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow-up
7. Standardized in vitro mapping with multiple core biopsies of total prostatectomy specimens: Localization and prediction of tumor volume and grade
8. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis
9. Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: The influence of prostate specific antigen cancer density
10. Tumor volume and prostate specific antigen: Implications for early detection and defining a window of curability
11. Intraglandular tumor extent and prognosis in prostatic carcinoma: Application of a grid method to prostatectomy specimens
12. Percentage carcinoma as a measure of prostate tumor size in radical prostatectomy tissue
13. Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice
14. The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens
15. Maximum tumor dimension provides a clinically useful and independently significant measure for predicting PSA-free survival following radical prostatectomy
16. An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer
17. Tissue-shrinkage correction factor in the calculation of prostate cancer volume
18. Prostate cancer volume
19. The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer
20. Simple post-processing of medical image
21. A comparison of pathological methods of measuring lung cancer volume
22. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer
23. Classification of localized untreated prostate cancer based on 791 men treated only with radical prostatectomy: Common ground for therapeutic trials and TNM subgroups